Related Experiment Video
Updated: Aug 6, 2026

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
RepID orchestrates CDH1 and CTNNB1 homeostasis to regulate metastatic potential in small cell lung cancer
Dong-Kyu Kim1, Jae-Hyun Jo1, Jong-Uk Park1
1Department of Biochemistry, Chungbuk National University, Cheongju, 28644, South Korea; Department of Biological Sciences and Biotechnology, Chungbuk National University, Cheongju, 28644, South Korea.
Abstract:
Small cell lung cancer (SCLC) is defined by its aggressive progression and early systemic dissemination, yet the molecular drivers that orchestrate its metastatic potential remain elusive. Here, we identify the replication initiation determinant protein (RepID), a chromatin-associated receptor for the CRL4 ubiquitin ligase complex, as a critical suppressor of the metastatic potential in SCLC. Analysis of patient-derived datasets revealed that RepID expression is significantly attenuated in metastatic tumors, correlating with poor clinical outcomes. Utilizing CRISPR-Cas9-mediated depletion, we demonstrate that RepID deficiency induces a profound phenotypic shift toward a spindle-like morphology, characterized by increased cellular polarity, cytoskeletal reorganization, and markedly enhanced migratory and invasive capacities in vitro. Mechanistically, RepID exerts dual-level control over epithelial homeostasis by maintaining CDH1 transcription through an ETS1-dependent axis, while simultaneously stabilizing the CTNNB1 protein. We find that loss of RepID triggers an aberrant surge in CUL1 abundance and neddylation, thereby accelerating CRL1-mediated ubiquitination and proteasomal degradation of CTNNB1. This RepID-dependent proteostatic control is reversible via inhibition of the neddylation or proteasome pathways, and re-expression of RepID effectively rescues cellular adhesion and attenuates invasive traits. Our findings establish RepID as a previously unrecognized molecular rheostat that constrains SCLC metastatic potential by integrating transcriptional regulation of epithelial integrity with post-translational control of the CRL1-CTNNB1 axis, providing a potential therapeutic vulnerability in recalcitrant SCLC.
Insights
Replication initiation determinant protein (RepID) suppresses small cell lung cancer (SCLC) metastasis. Loss of RepID enhances SCLC cell migration and invasion, revealing a potential therapeutic target for this aggressive cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metastasis
Background:
- Small cell lung cancer (SCLC) is characterized by aggressive progression and early metastasis.
- The molecular mechanisms driving SCLC metastasis remain largely unknown.
- Identifying novel suppressors of metastatic potential is crucial for therapeutic development.
Purpose of the Study:
- To identify molecular drivers that suppress metastatic potential in SCLC.
- To investigate the role of replication initiation determinant protein (RepID) in SCLC metastasis.
- To elucidate the mechanisms by which RepID regulates SCLC cell behavior.
Main Methods:
- Analysis of patient-derived SCLC datasets to correlate RepID expression with clinical outcomes.
- CRISPR-Cas9-mediated gene depletion to assess the functional impact of RepID loss.
- In vitro assays to evaluate cell morphology, migration, and invasion.
- Mechanistic studies involving gene transcription, protein stabilization, and ubiquitination pathways (e.g., CRL4, ETS1, CDH1, CTNNB1, CUL1 neddylation).
Main Results:
- RepID expression is significantly reduced in metastatic SCLC tumors, correlating with poor prognosis.
- RepID deficiency induces a mesenchymal transition, increasing SCLC cell polarity, cytoskeletal rearrangement, migration, and invasion.
- RepID maintains epithelial homeostasis by regulating CDH1 transcription via ETS1 and stabilizing CTNNB1 protein.
- Loss of RepID leads to increased CUL1 abundance and neddylation, accelerating CTNNB1 degradation.
- RepID-dependent proteostasis is reversible, and RepID re-expression restores adhesion and reduces invasion.
Conclusions:
- RepID acts as a critical suppressor of SCLC metastatic potential.
- RepID regulates SCLC metastasis through a dual mechanism involving transcriptional control of epithelial integrity and post-translational regulation of the CRL1-CTNNB1 axis.
- RepID represents a novel molecular rheostat and a potential therapeutic vulnerability in SCLC.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Canonical Wnt Signaling Pathway